Count (%) | |
---|---|
Clinical inquiries from DR-TB sites (N = 308) | |
Construction of treatment regimen | 119 (38.6) |
Management of adverse effect | 74 (24.0) |
Determination treatment duration | 67 (21.8) |
Validation of already prescribed regimen | 30 (9.7) |
Establishment of DR-TB diagnosis | 17 (5.5) |
Unknown | 1 (0.3) |
Recommendations of consilium (N = 471) | |
Construction of initial DR-TB regimen | 102 (21.7) |
Observation while on current regimen | 78 (16.6) |
Adherence counselling | 66 (14.0) |
Dose adjustment | 36 (7.6) |
Further diagnostic work up | 35 (7.4) |
Further clinical evaluation by specialist | 32 (6.8) |
Substitution of single agent in the regimen | 30 (6.4) |
Change of regimen (substituting 2 or more agents) | 25 (5.3) |
Adjunct medication | 23 (4.9) |
Withholding a single agent without substituting it | 15 (3.2) |
Withholding all DR-TB treatment for a while | 13 (2.8) |
Other recommendation | 16 (3.4) |